Mapping the effect of APOE ε4 on gray matter loss in Alzheimer's disease in vivo
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Previous studies suggest that in Alzheimer's disease (AD) the Apolipoprotein E (APOE) ε4 allele is associated with greater vulnerability of medial temporal lobe structures. However, less is known about its effect on the whole cortical mantle. Here we aimed to identify APOE-related patterns of cortical atrophy in AD using an advanced computational anatomy technique. We studied 15 AD patients carriers (ε4+, age:72±10SD years, MMSE:20±3SD) and 14 non-carriers (ε4-, age:69±9, MMSE:20±5) of the ε4 allele and compared them to 29 age-and-sex matched controls (age:70±9, MMSE:28±1). Each subject underwent a clinical evaluation, a neuropsychological battery, and high-resolution MRI. UCLA's cortical pattern matching technique was used to identify regions of local cortical atrophy. ε4+ and ε4- patients showed similar performance on neuropsychological tests (p>.05, t-test). Diffuse cortical atrophy was detected for both ε4+ (p=.0001, permutation test) and ε4- patients (p=.0001, permutation test) relative to controls, and overall gray matter loss was about 15% in each patients group. Differences in gray matter loss between carriers and non-carriers mapped to the temporal cortex and right occipital pole (20% greater loss in carriers) and to the posterior cingulate, left orbitofrontal and dorsal fronto-parietal cortex (5-15% greater loss in non-carriers). APOE effect in AD was not significant (p>.74, ANOVA), but a significant APOE by region (temporal vs fronto-parietal cortex) interaction was detected (p=.002, ANOVA), in both early and late-onset patients (p<.05, ANOVA). We conclude that the ε4 allele modulates disease phenotype in AD, being associated with a pattern of differential temporal and fronto-parietal vulnerability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · cited 2×
“ApoE, the protein coded by the APOE gene, is a lipid transport protein implicated in maintenance and repair of neuronal cells (Mahley, 1988), and current in vitro and animal model data strongly suggest that the ε4 allele is less efficient than other isoforms in these functions, throughmechanisms that involve neuronal…”
BackgroundPhases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 1×
“…heterogeneous disease, neuropathologically characterized by the accumulation of betaamyloid plaques (Abeta) and neurofibrillary tangles (NFT) in the brain (Braak and Braak, 1991; Delacourte et al., 1999; Price and Morris, 1999; Thal et al., 2002; Haroutunian et al., 1999; Haroutunian et al., 1998).”
BackgroundRestriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Dynamics of Gray Matter Loss in Alzheimer's Disease
Thompson, P. M., Hayashi, K. M., de Zubicaray, G., Janke, A. L., Rose, S. E., Semple, J., Herman, D., Hong, M. S., Dittmer, S. S., Doddrell, D. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00994.2003 · Cited by 1,132 · cited 1×
“This test computes the chance of the observed pattern occurring by accident by running n = 10,000 permutations of the variables of interest (diagnosis and APOE) at a threshold of p = .01 (Thompson et al., 2003).”
MethodSelf-citationApolipoprotein E polymorphism and Alzheimer's disease
Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., Gauthier, S., Davignon, J., Bouthillier, D., & Davignon, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91705-q · Cited by 1,108 · cited 4×
“…of the Apolipoprotein E (APOE) gene, that is present with a higher frequency in AD subjects than in the normal population (Strittmatter et al., 1993; Poirier et al., 1993; Corder et al., 1993; Tang et al., 1998; Kukull et al., 2002; Saunders et al., 2000), and lowers the mean age of onset of the…”
BackgroundInfluentialAutomated model-based tissue classification of MR images of the brain
Van Leemput, K., Maes, F., Vandermeulen, D., & Suetens, P. (1999) · IEEE Transactions on Medical Imaging · doi:10.1109/42.811270 · Cited by 1,024
Dementia and Alzheimer Disease Incidence: A Prospective Cohort Study
Kukull, W. A., Higdon, R., Bowen, J. D., McCormick, W. C., Teri, L., Schellenberg, G. D., van Belle, G., Jolley, L., & Larson, E. B. (2002) · Archives of Neurology · doi:10.1001/archneur.59.11.1737 · Cited by 806 · cited 2×
“…frequency in AD subjects than in the normal population (Strittmatter et al., 1993; Poirier et al., 1993; Corder et al., 1993; Tang et al., 1998; Kukull et al., 2002; Saunders et al., 2000), and lowers the mean age of onset of the disease in a dose-dependent fashion (Poirier et al., 1993;…”
Background
Cited by
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
Ossenkoppele, R., Schonhaut, D. R., Schöll, M., Lockhart, S. N., Ayakta, N., Baker, S. L., O’Neil, J. P., Janabi, M., Lazaris, A., Cantwell, A., et al. (2016) · Brain · doi:10.1093/brain/aww027 · Cited by 1,185
“Furthermore, patients with Alzheimer’s disease who carry the apolipoprotein E (APOE) e4 allele have shown greater medial temporal lobe vulnerability (Pievani et al., 2009; van der Flier et al., 2011; Ossenkoppele et al., 2013b; Lehmann et al., 2014) and post-mortem tau pathology (Beffert and…”
BackgroundBrain atrophy in Alzheimer’s Disease and aging
Pini, L., Pievani, M., Bocchetta, M., Altomare, D., Bosco, P., Cavedo, E., Galluzzi, S., Marizzoni, M., & Frisoni, G. B. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.002 · Cited by 836
Self-citationEarly-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele
van der Flier, W. M., Pijnenburg, Y. A., Fox, N. C., & Scheltens, P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70306-9 · Cited by 306
Wolk, D. A., Dickerson, B. C., Initiative, T. A. D. N., Weiner, M., Aiello, M., Aisen, P., Albert, M. S., Alexander, G., Anderson, H. S., Anderson, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001412107 · Cited by 248
Self-citationSex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans
Hua, X., Hibar, D. P., Lee, S., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.033 · Cited by 234
“…tensor-based morphometry, and cortical thickness maps (Baron et al., 2001; Chetelat et al., 2002; Frisoni et al., 2009; Karas et al., 2004; Pievani et al., 2009; Scahill et al., 2002; Smith, 2002; Smith and Jobst, 1996; Whitwell et al., 2007), based on cross-sectional data or smaller…”
BackgroundSelf-citation
Metadata
- Authors
- Pievani, M., Rasser, P. E., Galluzzi, S., Benussi, L., Ghidoni, R., Sabattoli, F., Bonetti, M., Binetti, G., Thompson, P. M., & Frisoni, G. B.
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 45
- Issue
- 4
- Pages
- 1090-1098
- ISSN
- 1053-8119 (ISSN-L)
- OpenAlex
- W1980727483
- Cited by
- 72
- References
- 26
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mapping the effect of APOE ε4 on gray matter loss in Alzheimer's disease in vivo. https://app.cochat.ai/papers/10.1016/j.neuroimage.2009.01.009
- The paper
- Pievani, M., Rasser, P. E., Galluzzi, S., Benussi, L., Ghidoni, R., Sabattoli, F., Bonetti, M., Binetti, G., Thompson, P. M., & Frisoni, G. B. (2009). Mapping the effect of APOE ε4 on gray matter loss in Alzheimer's disease in vivo. NeuroImage. https://doi.org/10.1016/j.neuroimage.2009.01.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.